Orthobiologics-EMEA Market Status and Trend Report 2013-2023
Report Summary
Orthobiologics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Orthobiologics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Orthobiologics 2013-2017, and development forecast 2018-2023
Main market players of Orthobiologics in EMEA, with company and product introduction, position in the Orthobiologics market
Market status and development trend of Orthobiologics by types and applications
Cost and profit status of Orthobiologics, and marketing status
Market growth drivers and challenges
The report segments the EMEA Orthobiologics market as:
EMEA Orthobiologics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Orthobiologics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DBM
Allograft
BMP
Viscosupplementation
Synthetic Bone Substitutes
Stem Cell
EMEA Orthobiologics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Spinal Fusion
Reconstructive Surgery
Trauma Repair
EMEA Orthobiologics Market: Players Segment Analysis (Company and Product introduction, Orthobiologics Sales Volume, Revenue, Price and Gross Margin):
Bone Biologics, Corp.
Medtronic
Bioventus LLC
Pioneer Surgical Technology
Smith & Nephew plc
Stryker Corporation
DePuy Synthes, Inc.
Genzyme
Osiris Therapeutics, Inc.
Globus Medical
Wright Medical Technology
Orthofix, Inc.
NuVasive, Inc.
Zimmer Biomet
Anthrex
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Orthobiologics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Orthobiologics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Orthobiologics 2013-2017, and development forecast 2018-2023
Main market players of Orthobiologics in EMEA, with company and product introduction, position in the Orthobiologics market
Market status and development trend of Orthobiologics by types and applications
Cost and profit status of Orthobiologics, and marketing status
Market growth drivers and challenges
The report segments the EMEA Orthobiologics market as:
EMEA Orthobiologics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Orthobiologics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DBM
Allograft
BMP
Viscosupplementation
Synthetic Bone Substitutes
Stem Cell
EMEA Orthobiologics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Spinal Fusion
Reconstructive Surgery
Trauma Repair
EMEA Orthobiologics Market: Players Segment Analysis (Company and Product introduction, Orthobiologics Sales Volume, Revenue, Price and Gross Margin):
Bone Biologics, Corp.
Medtronic
Bioventus LLC
Pioneer Surgical Technology
Smith & Nephew plc
Stryker Corporation
DePuy Synthes, Inc.
Genzyme
Osiris Therapeutics, Inc.
Globus Medical
Wright Medical Technology
Orthofix, Inc.
NuVasive, Inc.
Zimmer Biomet
Anthrex
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ORTHOBIOLOGICS
1.1 Definition of Orthobiologics in This Report
1.2 Commercial Types of Orthobiologics
1.2.1 DBM
1.2.2 Allograft
1.2.3 BMP
1.2.4 Viscosupplementation
1.2.5 Synthetic Bone Substitutes
1.2.6 Stem Cell
1.3 Downstream Application of Orthobiologics
1.3.1 Spinal Fusion
1.3.2 Reconstructive Surgery
1.3.3 Trauma Repair
1.4 Development History of Orthobiologics
1.5 Market Status and Trend of Orthobiologics 2013-2023
1.5.1 EMEA Orthobiologics Market Status and Trend 2013-2023
1.5.2 Regional Orthobiologics Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Orthobiologics in EMEA 2013-2017
2.2 Consumption Market of Orthobiologics in EMEA by Regions
2.2.1 Consumption Volume of Orthobiologics in EMEA by Regions
2.2.2 Revenue of Orthobiologics in EMEA by Regions
2.3 Market Analysis of Orthobiologics in EMEA by Regions
2.3.1 Market Analysis of Orthobiologics in Europe 2013-2017
2.3.2 Market Analysis of Orthobiologics in Middle East 2013-2017
2.3.3 Market Analysis of Orthobiologics in Africa 2013-2017
2.4 Market Development Forecast of Orthobiologics in EMEA 2018-2023
2.4.1 Market Development Forecast of Orthobiologics in EMEA 2018-2023
2.4.2 Market Development Forecast of Orthobiologics by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Orthobiologics in EMEA by Types
3.1.2 Revenue of Orthobiologics in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Orthobiologics in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Orthobiologics in EMEA by Downstream Industry
4.2 Demand Volume of Orthobiologics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Orthobiologics by Downstream Industry in Europe
4.2.2 Demand Volume of Orthobiologics by Downstream Industry in Middle East
4.2.3 Demand Volume of Orthobiologics by Downstream Industry in Africa
4.3 Market Forecast of Orthobiologics in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORTHOBIOLOGICS
5.1 EMEA Economy Situation and Trend Overview
5.2 Orthobiologics Downstream Industry Situation and Trend Overview
CHAPTER 6 ORTHOBIOLOGICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Orthobiologics in EMEA by Major Players
6.2 Revenue of Orthobiologics in EMEA by Major Players
6.3 Basic Information of Orthobiologics by Major Players
6.3.1 Headquarters Location and Established Time of Orthobiologics Major Players
6.3.2 Employees and Revenue Level of Orthobiologics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ORTHOBIOLOGICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Bone Biologics, Corp.
7.1.1 Company profile
7.1.2 Representative Orthobiologics Product
7.1.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Bone Biologics, Corp.
7.2 Medtronic
7.2.1 Company profile
7.2.2 Representative Orthobiologics Product
7.2.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Medtronic
7.3 Bioventus LLC
7.3.1 Company profile
7.3.2 Representative Orthobiologics Product
7.3.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Bioventus LLC
7.4 Pioneer Surgical Technology
7.4.1 Company profile
7.4.2 Representative Orthobiologics Product
7.4.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Pioneer Surgical Technology
7.5 Smith & Nephew plc
7.5.1 Company profile
7.5.2 Representative Orthobiologics Product
7.5.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Smith & Nephew plc
7.6 Stryker Corporation
7.6.1 Company profile
7.6.2 Representative Orthobiologics Product
7.6.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Stryker Corporation
7.7 DePuy Synthes, Inc.
7.7.1 Company profile
7.7.2 Representative Orthobiologics Product
7.7.3 Orthobiologics Sales, Revenue, Price and Gross Margin of DePuy Synthes, Inc.
7.8 Genzyme
7.8.1 Company profile
7.8.2 Representative Orthobiologics Product
7.8.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Genzyme
7.9 Osiris Therapeutics, Inc.
7.9.1 Company profile
7.9.2 Representative Orthobiologics Product
7.9.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Osiris Therapeutics, Inc.
7.10 Globus Medical
7.10.1 Company profile
7.10.2 Representative Orthobiologics Product
7.10.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Globus Medical
7.11 Wright Medical Technology
7.11.1 Company profile
7.11.2 Representative Orthobiologics Product
7.11.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Wright Medical Technology
7.12 Orthofix, Inc.
7.12.1 Company profile
7.12.2 Representative Orthobiologics Product
7.12.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Orthofix, Inc.
7.13 NuVasive, Inc.
7.13.1 Company profile
7.13.2 Representative Orthobiologics Product
7.13.3 Orthobiologics Sales, Revenue, Price and Gross Margin of NuVasive, Inc.
7.14 Zimmer Biomet
7.14.1 Company profile
7.14.2 Representative Orthobiologics Product
7.14.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Zimmer Biomet
7.15 Anthrex
7.15.1 Company profile
7.15.2 Representative Orthobiologics Product
7.15.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Anthrex
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORTHOBIOLOGICS
8.1 Industry Chain of Orthobiologics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORTHOBIOLOGICS
9.1 Cost Structure Analysis of Orthobiologics
9.2 Raw Materials Cost Analysis of Orthobiologics
9.3 Labor Cost Analysis of Orthobiologics
9.4 Manufacturing Expenses Analysis of Orthobiologics
CHAPTER 10 MARKETING STATUS ANALYSIS OF ORTHOBIOLOGICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Orthobiologics in This Report
1.2 Commercial Types of Orthobiologics
1.2.1 DBM
1.2.2 Allograft
1.2.3 BMP
1.2.4 Viscosupplementation
1.2.5 Synthetic Bone Substitutes
1.2.6 Stem Cell
1.3 Downstream Application of Orthobiologics
1.3.1 Spinal Fusion
1.3.2 Reconstructive Surgery
1.3.3 Trauma Repair
1.4 Development History of Orthobiologics
1.5 Market Status and Trend of Orthobiologics 2013-2023
1.5.1 EMEA Orthobiologics Market Status and Trend 2013-2023
1.5.2 Regional Orthobiologics Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Orthobiologics in EMEA 2013-2017
2.2 Consumption Market of Orthobiologics in EMEA by Regions
2.2.1 Consumption Volume of Orthobiologics in EMEA by Regions
2.2.2 Revenue of Orthobiologics in EMEA by Regions
2.3 Market Analysis of Orthobiologics in EMEA by Regions
2.3.1 Market Analysis of Orthobiologics in Europe 2013-2017
2.3.2 Market Analysis of Orthobiologics in Middle East 2013-2017
2.3.3 Market Analysis of Orthobiologics in Africa 2013-2017
2.4 Market Development Forecast of Orthobiologics in EMEA 2018-2023
2.4.1 Market Development Forecast of Orthobiologics in EMEA 2018-2023
2.4.2 Market Development Forecast of Orthobiologics by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Orthobiologics in EMEA by Types
3.1.2 Revenue of Orthobiologics in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Orthobiologics in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Orthobiologics in EMEA by Downstream Industry
4.2 Demand Volume of Orthobiologics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Orthobiologics by Downstream Industry in Europe
4.2.2 Demand Volume of Orthobiologics by Downstream Industry in Middle East
4.2.3 Demand Volume of Orthobiologics by Downstream Industry in Africa
4.3 Market Forecast of Orthobiologics in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORTHOBIOLOGICS
5.1 EMEA Economy Situation and Trend Overview
5.2 Orthobiologics Downstream Industry Situation and Trend Overview
CHAPTER 6 ORTHOBIOLOGICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Orthobiologics in EMEA by Major Players
6.2 Revenue of Orthobiologics in EMEA by Major Players
6.3 Basic Information of Orthobiologics by Major Players
6.3.1 Headquarters Location and Established Time of Orthobiologics Major Players
6.3.2 Employees and Revenue Level of Orthobiologics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ORTHOBIOLOGICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Bone Biologics, Corp.
7.1.1 Company profile
7.1.2 Representative Orthobiologics Product
7.1.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Bone Biologics, Corp.
7.2 Medtronic
7.2.1 Company profile
7.2.2 Representative Orthobiologics Product
7.2.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Medtronic
7.3 Bioventus LLC
7.3.1 Company profile
7.3.2 Representative Orthobiologics Product
7.3.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Bioventus LLC
7.4 Pioneer Surgical Technology
7.4.1 Company profile
7.4.2 Representative Orthobiologics Product
7.4.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Pioneer Surgical Technology
7.5 Smith & Nephew plc
7.5.1 Company profile
7.5.2 Representative Orthobiologics Product
7.5.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Smith & Nephew plc
7.6 Stryker Corporation
7.6.1 Company profile
7.6.2 Representative Orthobiologics Product
7.6.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Stryker Corporation
7.7 DePuy Synthes, Inc.
7.7.1 Company profile
7.7.2 Representative Orthobiologics Product
7.7.3 Orthobiologics Sales, Revenue, Price and Gross Margin of DePuy Synthes, Inc.
7.8 Genzyme
7.8.1 Company profile
7.8.2 Representative Orthobiologics Product
7.8.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Genzyme
7.9 Osiris Therapeutics, Inc.
7.9.1 Company profile
7.9.2 Representative Orthobiologics Product
7.9.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Osiris Therapeutics, Inc.
7.10 Globus Medical
7.10.1 Company profile
7.10.2 Representative Orthobiologics Product
7.10.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Globus Medical
7.11 Wright Medical Technology
7.11.1 Company profile
7.11.2 Representative Orthobiologics Product
7.11.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Wright Medical Technology
7.12 Orthofix, Inc.
7.12.1 Company profile
7.12.2 Representative Orthobiologics Product
7.12.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Orthofix, Inc.
7.13 NuVasive, Inc.
7.13.1 Company profile
7.13.2 Representative Orthobiologics Product
7.13.3 Orthobiologics Sales, Revenue, Price and Gross Margin of NuVasive, Inc.
7.14 Zimmer Biomet
7.14.1 Company profile
7.14.2 Representative Orthobiologics Product
7.14.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Zimmer Biomet
7.15 Anthrex
7.15.1 Company profile
7.15.2 Representative Orthobiologics Product
7.15.3 Orthobiologics Sales, Revenue, Price and Gross Margin of Anthrex
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORTHOBIOLOGICS
8.1 Industry Chain of Orthobiologics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORTHOBIOLOGICS
9.1 Cost Structure Analysis of Orthobiologics
9.2 Raw Materials Cost Analysis of Orthobiologics
9.3 Labor Cost Analysis of Orthobiologics
9.4 Manufacturing Expenses Analysis of Orthobiologics
CHAPTER 10 MARKETING STATUS ANALYSIS OF ORTHOBIOLOGICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
